FSD Pharma
Dr. Sima Salahshor holds a bachelor’s degree in Clinical Chemistry, a Master’s in Molecular Biology, and a Ph.D. in Medical Genetics from Karolinska Institute, Sweden. She is a certified Project Management Professional (PMP) and is an adjunct professor at the University of Toronto’s Faculty of Medicine. She has over 20 years of experience in oncology and cell signaling research working at the Karolinska Institute (Sweden), University Health Network (UHN), and Lunenfeld Research Institute at Mount Sinai Hospital (Canada).
She has published numerous pre-reviewed articles in cancer diagnostic and biomarker discovery and development. For ten years, she led and managed a scientific-business advisory firm focusing on life-sciences and healthcare-related projects and programs. During that time, she worked extensively with early-stage as well as larger corporate companies and has experience in product evaluation, clinical studies, early stage investment, commercialization, and industry partnership development.
This person is not in any offices
FSD Pharma
FSD Pharma is committed to the pursuit of developing innovative novel biotechnologies to bring advanced neurodegenerative and mental health treatments to market.